Targeted Therapeutics in Melanoma (Current Clinical Oncology) - Image 1

£80.27

Humana Targeted Therapeutics in Melanoma (Current Clinical Oncology)

Name: Targeted Therapeutics in Melanoma (Current Clinical Oncology)
Brand: Humana
Price: 80.09 GBP
Availability: InStock

Oncology

Price History & Forecast

Last 50 days • 50 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 50 days • 1 price levels

Days at Price

Price Analysis

Most common price: £80 (50 days, 100.0%)

Price range: £80 - £80

Price levels: 1 different prices over 50 days

Description

Product Description This book describes recent ground-breaking developments in melanoma treatment in the arena of targeted therapeutics. The contents explore both established signal transduction inhibitors and the fascinating emerging realm of molecularly-guided immunotherapies. Review From the reviews:“This book is a multiauthored edition, with contributors and editors who are experts in their fields regarding new therapeutic approaches for melanoma. … It is a highly technical volume and is directed toward true melanoma mavins, both clinical and laboratory research based, who continue to work at the translational interface. … I recommend this to all those clinical, translational, and laboratory investigators committed to moving the field forward in the development of treatment for melanoma.” (Janice P. Dutcher, Medical Oncology, Vol. 30, 2013) From the Back Cover Melanoma is an increasingly important public health problem. Although the cause of most malignant melanomas – over-exposure to ultraviolet light – is well known, effective treatment has remained challenging. The past several years have been marked by extraordinary developments in melanoma treatment in the arena of targeted therapeutics. This book describes these ground-breaking discoveries and their implications for clinical use. As melanoma biology is increasingly understood, so the development of targeted therapies for this disease is spurred ahead. This book covers both established signal transduction inhibitors and the fascinating emerging realm of molecularly-guided immunotherapies. This benchmark book provides the most up-to-date information on the new breed of melanoma therapies. Composed of the works of major researchers and clinicians, this book offers new insights, novel approaches, and promising data for effective treatment planning. Illuminating the latest advances in the field, it is a solid resource for clinical oncologists, translational scientists, and basic cancer researchers.

Product Specifications

Brand: Humana
Format: paperback
ASIN: 1627038760
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Diseases & Disorders > Oncology
Domain: Amazon UK
Release Date: 03 March 2014
Listed Since: 27 March 2014

Barcode

No barcode data available

Humana Targeted Therapeutics in Melanoma (Current Clinical Oncology)

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Diagnostic and Prognostic Biomarkers and Therapeutic Targets in Melanoma (Current Clinical Pathology)

Diagnostic and Prognostic Biomarkers and Therapeutic Targets in Melanoma (Current Clinical Pathology)

Human Melanoma: From Basic Research to Clinical Application

Immunotherapy of Melanoma

Immunotherapy of Melanoma

Melanoma: Translational Research and Emerging Therapies: 8 (Translational Medicine)

New Therapies in Advanced Cutaneous Malignancies

Macromolecular Anticancer Therapeutics (Cancer Drug Discovery and Development)

Macromolecular Anticancer Therapeutics (Cancer Drug Discovery and Development)

Cutaneous Melanoma, Fifth Edition

Targeted Therapies: Mechanisms of Resistance (Molecular and Translational Medicine)

Springer - Novel Immunotherapeutic Approaches to Cancer Treatment

Springer - Novel Immunotherapeutic Approaches to Cancer Treatment

Melanoma: A Modern Multidisciplinary Approach

Targeted Therapies: Mechanisms of Resistance (Molecular and Translational Medicine)

BRAF Targets in Melanoma: Biological Mechanisms, Resistance, and Drug Discovery: 82 (Cancer Drug Discovery and Development, 82)

Clinical Immuno-Oncology

Immunotherapy in Translational Cancer Research (Translational Oncology)

Cancer Therapeutics: Experimental and Clinical Agents (Cancer Drug Discovery and Development)

MELANOMA MOLECULAR BIOLOGY: Molecular Biology, Risk Factors & Treatment Options (Cancer Etiology, Diagnosis and Treatments: Dermatology - Laboratory and Clincal Research)

Molecular Diagnostics for Melanoma: Methods and Protocols: 1102 (Methods in Molecular Biology, 1102)

Skin Cancer - A World-Wide Perspective

Melanoma

Targeted Therapies in Oncology